Human Xt-M (HUMX.M) AI Stock Analysis

• Market Cap: 6.10M
• Dividend Yield: N/A
• Average Volume (3M): 1.70K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.33
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IL
• Employees: 21
• Sector: Technology
• Sector Strength: 88
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 26,756,048
• 10 Day Avg. Volume: 1,765
• 30 Day Avg. Volume: 1,695
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 40 Underperform
• Price Target: ―

Human Xt's stock performance is weighed down by significant financial difficulties, including declining revenues and persistent losses. The technical analysis is mixed, showing some potential for volatility but no clear trend. Valuation metrics are unattractive due to negative earnings. The company's dire financial health is the primary concern, overshadowing any technical or valuation considerations.

Positive Factors

Debt-Free Status

Being debt-free provides Human Xt with financial flexibility and reduces the risk of insolvency, allowing the company to focus on restructuring efforts without the burden of interest payments.

Strategic Alliances

Partnerships with enterprise clients enable Human Xt to tailor its offerings to specific needs, potentially increasing its market penetration and revenue stability over time.

Reduced Capital Expenditure

Lower capital expenditure can help improve free cash flow, allowing Human Xt to allocate resources more efficiently towards operational restructuring and strategic initiatives.

Negative Factors

Declining Revenue

The significant drop in revenue indicates potential loss of market share or demand, which could undermine the company's ability to sustain operations and invest in growth.

Negative Margins

Persistently negative profit margins reflect severe cost inefficiencies or pricing pressures, hindering the company's ability to achieve profitability and financial health.

Eroding Equity Base

A declining equity base signifies reduced financial stability and investor confidence, potentially limiting the company's ability to raise capital or invest in future growth.

Human Xt-M Business Overview & Revenue Model

Company Description

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopolar Hook; and Needle Holder. The company was incorporated in 2012 and is based in Netanya, Israel.

How the Company Makes Money

Human Xt (HUMX) generates revenue through the sale of its smart wearable devices and augmented reality applications, which are available to both individual consumers and corporate clients. The company also offers AI-driven software solutions on a subscription basis, providing continuous updates and support. Key revenue streams include direct product sales, subscription fees for software services, and partnerships with technology firms to integrate HUMX's solutions into broader ecosystems. Additionally, strategic alliances with enterprise clients in various industries allow the company to create customized solutions that cater to specific business needs, thereby enhancing its earnings.

Human Xt-M Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Human Xt-M Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 25.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HUMX.M, the sentiment is Negative. The current price of 25.8 is above the 20-day moving average (MA) of 23.30, above the 50-day MA of 25.00, and below the 200-day MA of 29.64, indicating a bearish trend. The MACD of -0.58 indicates Negative momentum. The RSI at 15.14 is Positive, neither overbought nor oversold. The STOCH value of 99.71 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HUMX.M.

Human Xt-M Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
HUMX.M	40 Underperform	6.10M	―	―	―	―	―